This article shows that Remdesivir does not offer a benefit if we analyze the clinical endpoints of the study. However, it does show that Remdesivir may provide a faster recovery.

Link to the article.
doi: Link

To quote this article in bibliography:

Yeming Wang, Dingyu ZhangMD, Prof Guanhua DuPhDe, Prof Ronghui DuMD, ProfJianping ZhaoMDg, Prof Yang Jin MDh, Prof Shouzhi Fu MD, Prof Ling Gao MD. Prof Zhenshun Cheng MD . “Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial." The Lancet 395, no. 10236 (2020): 1569-1578. https://doi.org/10.1016/S0140-6736(20)31022-9

Join us in the social media!

Click here to subscribe to our Telegram Channel!

Click here to join to our Telegram Group for discussions

Monitor Image downloaded form iStock. A Standard License was purchased which allows the use of the file for any personal, business or commercial purposes that aren't otherwise restricted by the license.